top of page
Predicting the Outcome of Clinical Trials
Mimi-Q is revolutionizing drug development with an innovative platform that accelerates the process and slashes costs by over 80%. By predicting clinical trial outcomes through virtual patient modeling and adaptive in vitro testing, our technology significantly reduces development timelines and improves success rates.
Virtual Patient Generator
-
Our proprietary software enables describing drug behavior in human populations, while including diverse patient characteristics
Wet Lab Disease Response Model
-
Our patented technology is developed to generate data on response after the drug administration
Virtual Clinical Trial Simulator
-
Mimi-Q has developed an innovative platform that seamlessly bundles data from diverse sources, that predicts the results for any possible scenario.
bottom of page